{"id":53308,"date":"2020-08-25T15:11:00","date_gmt":"2020-08-25T12:11:00","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/oxford-covid-19-vaccine-may-go-before-regulators-this-year-scientist\/"},"modified":"2020-08-25T15:11:00","modified_gmt":"2020-08-25T12:11:00","slug":"oxford-covid-19-vaccine-may-go-before-regulators-this-year-scientist","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/oxford-covid-19-vaccine-may-go-before-regulators-this-year-scientist\/","title":{"rendered":"#Oxford COVID-19 vaccine may go before regulators this year: scientist"},"content":{"rendered":"<p>&#8220;<strong>#Oxford COVID-19 vaccine may go before regulators this year: scientist<\/strong>&#8221;<\/p>\n<div>\n                        Clinical trials for the Oxford coronavirus vaccine may provide enough safety and efficacy data for it to be given to regulators this year \u2013 but a scientist leading the trials insists that corners cannot be cut to speed up emergency use <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/download-scripts-themes-apps\/\" data-internallinksmanager029f6b8e52c=\"9\" title=\"Download Scripts &amp; Themes &amp; Apps\" target=\"_blank\" rel=\"noopener\">app<\/a>roval, according to reports.<\/p>\n<p>Prof. Andrew Pollard, director of the Oxford Vaccine Group, told BBC Radio 4 that they have to first \u201cdemonstrate a vaccine works and is safe, and then to go through the processes of regulators looking at that very carefully to make sure everything\u2019s been done correctly.<\/p>\n<p>\u201cBut it is also just possible that if the cases accrue rapidly in the clinical trials that we could have that data to put before regulators this year, and then there would be a process that they go through in order to make a full assessment of the data,\u201d he said, according to Yahoo <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/news\/\" data-internallinksmanager029f6b8e52c=\"2\" title=\"News\" target=\"_blank\" rel=\"noopener\">News<\/a>.<\/p>\n<p>The UK\u2019s chief medical officer, Prof. Chris Whitty, has said a vaccine may not be ready until next winter, according to Yahoo News.<\/p>\n<p>\u201cI think that Chris Whitty is quite rightly being cautious, that it could take as long as that to first of all demonstrate a vaccine works and is safe,\u201d Pollard said.<\/p>\n<p>Asked about a timeframe, he said: \u201cThat depends very much on the number of cases that occur in the weeks and months ahead.<\/p>\n<p>\u201cEven with 1,000 people eventually you\u2019ll have enough information to know whether or not a vaccine works, but that could take years,\u201d Pollard said.<\/p>\n<p>\u201cSo, having 20,000 people in our trials already means that that period of time will be shorter, but unfortunately I can\u2019t quite predict the future about how many cases are going to occur,\u201d he said.<\/p>\n<p>Pollard\u2019s comments come as the Trump administration is weighing a fast-track process that would allow AstraZeneca\u2019s coronavirus vaccine to be used in the US before November\u2019s presidential election, according to a new report.<\/p>\n<p>One plan under consideration would see the Food and Drug Administration issue an \u201cemergency use authorization\u201d for the British drugmaker\u2019s vaccine candidate in October, the Financial Times reported Sunday, citing three people briefed on the plan.<\/p>\n<p>AstraZeneca\u2019s vaccine, developed with the University of Oxford, is one of six candidates Team Trump is supporting through Operation Warp Speed \u2014 its initiative to deliver a safe and effective COVID-19 inoculation by early next year.<\/p>\n<p>The authorization, known as an EUA, would be based on forthcoming results from a study involving 10,000 people in the UK \u2014 even though federal agencies have said a study of 30,000 people would be needed to win such an approval.<\/p>\n<p>Pollard said he hoped that 50,000 people would be involved in the clinical trial for the Oxford vaccine candidate, Yahoo News reported.<\/p>\n<p>He stressed, however, that the size of the trial \u201cisn\u2019t really the issue.\u201d<\/p>\n<p>\u201cWhat you need is to have enough cases accruing during the time of observation in the trials,\u201d Pollard said. \u201cThe size of the trial is critical, first of all for safety \u2013 so you want to have good evidence that, after a large number of people have been vaccinated, you\u2019ve got good evidence or safety around the vaccine.<\/p>\n<p>\u201cAnd, secondly, you want to be able to show whether the vaccine works, and the size of the trial actually is determined largely by what the attack rate of the disease is in the study population,\u201d he continued.<\/p>\n<p>\u201cAnd so, if you\u2019ve got a very, very rare disease, you need an enormous trial size, in order to be able to show whether the vaccine works. But in a situation like that at the moment coronavirus, depending on which region or country you are in, the size of the trial could be smaller or bigger just depending on how many cases are happening in that community at the time.\u201d<\/p>\n<p>Pollard added: \u201cThere are a number of trials that we\u2019re running from Oxford here in the UK, in Brazil, and also in South Africa, and the combined size of those three trials together is around about 20,000 people, and AstraZeneca are moving forwards in their trials in the US, hoping to start enrolling 30,000 people.<\/p>\n<p>\u201cSo within the trials of the vaccine that was developed here at Oxford University, we\u2019d expect to have perhaps 50,000 or more people in the trials in total,\u201d he said.<\/p>\n<p>Responding to reports the US is planning an EUA for the Oxford vaccine, Pollard said: \u201cEmergency use authorizations are well established by regulators both in the United States and in Europe.<\/p>\n<p>\u201cIn fact, you may be aware just this week, the FDA has granted emergency use authorization for plasma therapy.\u201d\n            <\/p><\/div>\n<blockquote>\n<p style=\"text-align: center;\"><strong>If you want to read more News articles, you can visit our <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/en.buradabiliyorum.com\/general\/\" target=\"_blank\" rel=\"noopener noreferrer\">General category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\"><strong>if you want to <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/watch-movies-tv-seriess\/\" data-internallinksmanager029f6b8e52c=\"8\" title=\"Watch Movies &amp; TV Series\" target=\"_blank\" rel=\"noopener\">watch Movies<\/a> or Tv Shows go to <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/dizi.buradabiliyorum.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Dizi.BuradaBiliyorum.Com<\/a> <\/span> for forums sites go to <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/forum.buradabiliyorum.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<p><span style=\"color: black;\"><a style=\"color: #ff9900;\" href=\"https:\/\/nypost.com\/2020\/08\/25\/oxford-covid-19-vaccine-may-go-before-regulators-this-year-scientist\/\" target=\"_blank\" rel=\"noopener noreferrer\">Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;#Oxford COVID-19 vaccine may go before regulators this year: scientist&#8221; Clinical trials for the Oxford coronavirus vaccine may provide enough safety and efficacy data for it to be given to regulators this year \u2013 but a scientist leading the trials insists that corners cannot be cut to speed up emergency use approval, according to reports&#8230;.<\/p>\n","protected":false},"author":1,"featured_media":53309,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[1],"tags":[58240],"class_list":["post-53308","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","tag-oxford-covid-19-vaccine-may-go-before-regulators-this-year-scientist"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/53308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=53308"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/53308\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/53309"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=53308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=53308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=53308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}